FORM 10-QSB

                       SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D. C. 20549


             QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE
                         SECURITIES EXCHANGE ACT OF 1934


                    FOR THE QUARTER ENDED: DECEMBER 31, 2002

                        COMMISSION FILE NUMBER: 333-36522

                       WICKLIFFE INTERNATIONAL CORPORATION
                 -----------------------------------------------
             (EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)

                                NEVADA 75-2853946
                       ----------------------- ----------
                      (STATE OF INCORPORATION) (IRS ID NO.)


                709-B WEST RUSK, SUITE 580, ROCKWALL, TEXAS        75087
      ----------------------------------------------------------- --------
               (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) (ZIP CODE)

        REGISTRANT'S TELEPHONE NUMBER, INCLUDING AREA CODE:  214-212-2307

CHECK  WHETHER THE ISSUER (1) FILED ALL REPORTS  REQUIRED TO BE FILED BY SECTION
13 OR 15(D) OF THE SECURITIES EXCHANGE ACT DURING THE PAST TWELVE MONTHS (OR FOR
SUCHSHORTER  PERIOD THAT THE REGISTRANT WAS REQUIRED TO FILE SUCH REPORTS),  AND
(2) HAS BEEN SUBJECT TO SUCH FILING  REQUIREMENTS  FOR THE PAST 90 DAYS.
YES [X] NO [ ].

            SHARES OF COMMON STOCK OUTSTANDING AT DECEMBER 31, 2002:

                                    1,669,180













<PAGE>



                                TABLE OF CONTENTS



PART I - FINANCIAL INFORMATION                                       Page Number


Item  1.          Financial Statements                                  1 - 4

Item  2.          Management's Discussion and Analysis
                  of Financial Condition and Results of Operations      5


PART II - OTHER INFORMATION                                             6



<PAGE>

<TABLE>

<CAPTION>



                       WICKLIFFE INTERNATIONAL CORPORATION

                                 BALANCE SHEETS
                       December 31, 2002 and June 30, 2002



                           ASSETS
                           ------
                                                                               Dec 31, 2002
                                                                                (Unaudited)      June 30, 2002
                                                                             ------------------------------------
<S>                                                                          <C>                 <C>



TOTAL ASSETS                                                                                $0                $0
                                                                             ====================================



                 LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
                 ----------------------------------------------

LIABILITIES
     Accounts payable                                                                   $4,838            $2,625
                                                                             ------------------------------------
TOTAL CURRENT LIABILITIES                                                                4,838             2,625

STOCKHOLDERS' EQUITY (DEFICIT)
    Common stock, $0.001 par value, 25,000,000 shares
          authorized, 1,669,180 shares issued and outstanding                            1,669             1,669
    Additional paid-in-capital                                                         176,172           174,132
    Accumulated Deficit                                                               (182,679)         (178,426)
                                                                             ------------------------------------
        Total Stockholders' Equity (Deficit)                                            (4,838)           (2,625)
                                                                             ------------------------------------

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)                                        $0                $0
                                                                             ====================================

</TABLE>










See accompanying notes to interim condensed financial statements             F-1

<PAGE>

<TABLE>

<CAPTION>


                       WICKLIFFE INTERNATIONAL CORPORATION

                             STATEMENT OF OPERATIONS
              Three and Six Months ended December 31, 2002 and 2001



                                                        Three months      Three months       Six Months        Six Months
                                                            ended             ended             ended             ended
                                                        Dec 31, 2002      Dec 31, 2001      Dec 31, 2002      Dec 31, 2001
                                                         (Unaudited)       (Unaudited)       (Unaudited)       (Unaudited)
                                                      ------------------------------------------------------------------------
<S>                                                   <C>                 <C>               <C>               <C>


REVENUE                                                              $0                $0                $0                $0

OPERATING EXPENSE:
    Depreciation and amortization                                                     224                                 447
    General and administrative                                      857             2,791             4,267            11,741
                                                      ------------------------------------------------------------------------
        Total Operating Expense                                     857             3,015             4,267            12,188
                                                      ------------------------------------------------------------------------

NET LOSS                                                          ($857)          ($3,015)          ($4,267)         ($12,188)
                                                      ========================================================================


Weighted average shares outstanding                           1,669,180         1,630,950         1,669,180         1,630,950
                                                      ========================================================================

LOSS PER SHARE                                                   ($0.00)           ($0.00)           ($0.00)           ($0.01)
                                                      ========================================================================

</TABLE>













See accompanying notes to interim condensed financial statements             F-2

<PAGE>

<TABLE>

<CAPTION>

                       WICKLIFFE INTERNATIONAL CORPORATION

                             STATEMENT OF CASH FLOWS
                   Six Months ended December 31, 2002 and 2001



                                                                    Six Months        Six Months
                                                                       ended             ended
                                                                   Dec 31, 2002      Dec 31, 2001
                                                                    (Unaudited)       (Unaudited)
                                                                 ------------------------------------
<S>                                                              <C>                 <C>

CASH FLOWS FROM OPERATING ACTIVITIES:
    Net loss                                                               ($4,267)         ($12,188)
    Adjustments to reconcile net loss to net
            cash (used) by operating activities:
                Depreciation & amortization                                                      447
                Increase in current liabilities                              2,212             1,926
                Decrease in current prepaid expenses                                           8,065
                                                                 ------------------------------------
NET CASH USED BY OPERATING ACTIVITIES:                                      (2,055)           (1,750)

CASH FLOWS FROM INVESTING ACTIVITIES:                                            0                 0

CASH FLOWS FROM FINANCING ACTIVITIES:
    Expenses paid by shareholders                                            2,055             1,750
                                                                 ------------------------------------
    Total cash flows from financing activities                               2,055             1,750

                                                                 ------------------------------------

NET INCREASE IN CASH                                                            $0                $0

CASH, BEGINNING OF PERIOD                                                        0                 0
                                                                 ------------------------------------

CASH, END OF PERIOD                                                             $0                $0
                                                                 ====================================


</TABLE>

















See accompanying notes to interim condensed financial statements             F-3

<PAGE>


                       WICKLIFFE INTERNATIONAL CORPORATION

                 NOTES TO INTERIM CONDENSED FINANCIAL STATEMENTS
                                December 31, 2002

Note A - Presentation

The condensed  balance sheet of the Company as of December 31, 2002, the related
condensed  statements of operations  for the three and six months ended December
31, 2002 and 2001,  and the  statements  of cash flows for the six months  ended
December  31,  2002 and 2001  included  in the  condensed  financial  statements
include all adjustments (consisting of normal,  recurring adjustments) necessary
to summarize fairly the Company's  financial position and results of operations.
The results of operations  for the three months ended  December 31, 2002 are not
necessarily  indicative  of the results of  operations  for the full year or any
other interim  period.  The  information  included in this Form 10-QSB should be
read in  conjunction  with  Management's  Discussion  and Analysis and Financial
Statements  and notes  thereto  included  in the  Company's  June 30,  2002 Form
10-KSB.


















                                                                             F-4


<PAGE>



Item 2:           MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
                  CONDITION AND RESULTS OF OPERATIONS.


Plan of Operations

The Registrant was in the business of searching for  hospitality  properties but
because of the  deteriorating  market has determined  that it will search for an
ongoing  business  that it can  purchase  soley for stock  rather than having to
raise capital to offer cash for a business enterprise. The intent is to maximize
value for the  shareholders in a prudent time frame.  The Company  currently has
sufficient  cash to sustain  itself in its  current  non-operational  status for
approximately  six  months.  If the  Company  is unable to  acquire  an  ongoing
business  before  the  expiration  of such  time  period,  it will need to raise
additional capital to satisfy its ongoing costs and expenses.

Business

Wickliffe   International   Corporation  referred  to  as  (the  "Company")  was
incorporated on June 30, 1999 under the laws of the State of Nevada. The Company
currently  has no  business  operations  and is  seeking  to  acquire an ongoing
business.

On June 20, 2002, the Company entered into a share exchange agreement to acquire
Werke  Pharmaceuticals,  Inc.  (WERKE),  a  private  Delaware  corporation,  and
Shenyang  Tianwei  Pharmaceutical  Factory (STPF), a Chinese  Corporation  ("the
WERKE  Exchange  Transaction").  WERKE and STPF were  joint  owners of  Shenyang
Tianwei Werke  Pharmaceutical  Co. Ltd.  ("STWP),  a  Sino-foreign  equity joint
venture  formed in 2001 to finance and expand an existing  northern  China-based
pharmaceutical  manufacturing  and sales  company.  Formerly,  through the joint
venture structure,  55% of STWP was owned by STPF and 45% was owned by WERKE. On
December  9,  2002,  STPF  exercised  its  right,  under  the terms of the joint
venture,  to convert its interest in STWP into equity in WERKE so that WERKE now
owns 100% of STWP.

The  Closing  of WERKE  Exchange  Transaction  will be held as soon as  possible
following  the  completion  of the Audit of WERKE and STWP,  of which events are
conditions   precedent  to  the  Closing.   Additionally,   the  WERKE  Exchange
Transaction may be terminated by mutual consent of both parties in writing or by
either  the  shareholders  of Werke or the  Company if there has been a material
misrepresentation  or material  breach of any  warranty or covenant by any other
party  that is not  cured by August  30,  2002 or such  later  date as agreed by
parties. At present, the parties anticipate that the Closing will occur, however
there can be no assurance.  Upon  completion of the Werke Exchange  Transaction,
the WERKE  Shareholders have agreed to transfer all of their outstanding  shares
of WERKE stock to the  Company in  consideration  for  11,000,000  newly  issued
shares  of the  Company's  common  stock.  The  stock  will be  issued  to WERKE
Shareholders  on a pro rata basis,  in the same  proportion as the percentage of
their ownership interest in WERKE.

Employees

As of December 31, 2002 the Company did not employ any personnel.






                                        5



<PAGE>



PART II.     OTHER INFORMATION


Item  1.     Legal Proceedings.

         The Company is not involved in any legal proceedings.

Item  2.     Changes in Securities.

         Registrant has made no changes in its securities.

Item  3.     Defaults Upon Senior Securities.

         Registrant has no senior securities and accordingly no defaults.

Item  4.     Submission of Matters to a Vote of Security Holders.

         Registrant submitted no matters to a vote of security holders.

Item  5.     Other Information.

         None.

Item 6.      Exhibits and Reports on Form 8-K.

               *  Share  Exchange  Agreement  between the Company and Douglas C.
                  MacLellan    (the    "Shareholders    Representative"),     as
                  representative  of the persons listed in the persons listed in
                  Exhibit A hereof (the "Werke Shareholders"),  being the owners
                  of record of all of the issued and outstanding  stock of Werke
                  Pharmaceuticals,  Inc., a Delaware corporation ("WERKE");  and
                  Shenyang Tianwei Pharmaceutical Factory, a Chinese corporation
                  ("STPF"), is entered into as of June 20, 2002.


* Previously filed


<PAGE>




                                   SIGNATURES

Pursuant to the requirements of the Section 13 or 15(d) of the Securities Act of
1934,  the  Registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.


                              WICKLIFFE INTERNATIONAL CORPORATION


                              By: /s/ Charles Smith
                              --------------------------------------------
                              Name:   Charles Smith
                              Title:  Chairman and Chief Executive Officer


Pursuant to the requirements of the Securities Act of 1934, this report has been
signed below by the  following  persons on behalf of the  Registrant  and in the
capacities indicated below on February 10, 2003.


            SIGNATURE                        TITLE
=============================    ===============================================

        /s/ CHARLES SMITH        Chairman, Chief Executive Officer and Director
        ---------------------
            Charles Smith

        /s/ CHARLES SMITH        President, Chief Operating Officer and Director
        ---------------------
            Charles Smith

        /s/ CHARLES SMITH        Chief Financial Officer (as principal financial
        ---------------------    officer and principal accounting officer of
            Charles Smith        Wickliffe International Corporation)










                                        7



<PAGE>



                                 CERTIFICATIONS

I, Charles Smith, certify that:


     1.   I have  reviewed  this  quarterly  report on Form 10-QSB of  Wickliffe
          International Corporation

    2.    Based on my knowledge,  this annual report does not contain any untrue
          statement  of a  material  fact  or  omit to  state  a  material  fact
          necessary to make the statements  made, in light of the  circumstances
          under which such  statements were made, not misleading with respect to
          the period covered by this annual report; and

    3.    Based on my knowledge,  the financial statements,  and other financial
          information  included in this  annual  report,  fairly  present in all
          material respects the financial  condition,  results of operations and
          cash flows of the registrant as of, and for, the periods  presented in
          this annual report.


Date: February 10, 2003


By:   /s/ Charles Smith
      ------------------
Name:     Charles Smith
Title: Chairman, Chief Executive Officer and Chief Financial Officer












                                        8




<PAGE>


         Pursuant  to 18  U.S.C.  ss.1350,  as  created  by  Section  906 of the
Sarbanes-Oxley Act of 2002, the undersigned  officer of Wickliffe  International
Corporation (the Company) hereby certifies, to such officers knowledge, that:

          (i) the  accompanying  Quarterly  Report on Form 10-QSB of the Company
    for the quarter ended December 31, 2002 (the Report) fully complies with the
    requirements  of  Section  13(a) or Section  15(d),  as  applicable,  of the
    Securities Exchange Act of 1934, as amended; and

          (ii) the information  contained in the Report fairly presents,  in all
    material respects,  the financial condition and results of operations of the
    Company.


Date: February 10, 2003


By:   /s/ Charles Smith
      -----------------
Name:     Charles Smith
Title: Chairman, Chief Executive Officer  and Chief Financial Officer